Assertio Therapeutics’ s corporate name change from “Depomed, Inc.” to “Assertio Therapeutics, Inc.” became effective August 14. The company’s common stock will begin trading under a new ticker symbol “ASRT” and a new CUSIP number, 04545L 107, at the opening of trading August 15. The company also completed the relocation of its corporate headquarters from Newark, CA, to Lake Forest, IL.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.